1. Mailankody, S. & Prasad, V. Five years of cancer drug approvals: innovation, efficacy, and costs. JAMA Oncol. 1, 539–540 (2015).
2. Goldstein, D. A. et al. Global differences in cancer drug prices: a comparative analysis [abstract]. J. Clin. Oncol. 34 (Suppl.), LBA6500 (2016).
3. Mullard, A. US drug spending hits $425 billion. Nat. Rev. Drug Discov. 15, 299 (2016).
4. Fox, M. Global cancer drug market grows to $107 billion. NBC News
http://www.nbcnews.com/health/cancer/global-cancer-drug-market-grows-107-billion-n584481
(2016).
5. Silverman, E. Sharp rise in cancer drug spending forecast, but access remains a problem. STATNews
https://www.statnews.com/pharmalot/2016/06/02/spending-cancer-drugs-forecast-access-still-problem/
(2016).